Keycare Patient Diary UK

Keycare Patient Diary UK

Merck Sharp & Dohme LLC
2022年05月27日
  • 5.0

    Android OS

关于Keycare Patient Diary UK

A diary to help and support lung cancer patients through their treatment journey

The Keycare mobile application or K-app is a digital diary designed to help you with your MSD treatment for lung cancer with tracking symptoms, taking notes, accessing information about the specific treatment and allowing navigation to useful links which offer additional support. This application also allows you to send reports to your medical team easily so they can regularly monitor how you're feeling.

Please note, this app is intended for patients on a specific MSD treatment and you will need a registration code before you can start using it so please ask your healthcare professional for this. Download this application today to start exploring it.

This mobile application is intended for use in the UK only. Further information can be found in the terms of use in the app. Further information on our data protection measures can be found on our company privacy page at www.msdprivacy.com/uk/en/.

If you wish to report an adverse event related to a specific MSD product, please email us at [email protected] or call us: +44 (0) 1992 467272.

For any technical difficulties or support relating to the Keycare app, please send an email to [email protected].*

*Please note, this email address is monitored and managed by a third party provider.

This mobile application has been developed and is owned by Merck Sharp & Dohme (UK) Limited ("MSD").

更多

最新版本3.1.1的更新日志

Last updated on 2022年05月27日
Minor bug fixes and improvements. Install or update to the newest version to check it out!
更多

视频和屏幕截图

  • Keycare Patient Diary UK 海报
  • Keycare Patient Diary UK 截图 1
  • Keycare Patient Diary UK 截图 2
  • Keycare Patient Diary UK 截图 3
APKPure 图标

在APKPure上极速安全下载应用

一键安装安卓XAPK/APK文件!

下载 APKPure
thank icon
We use cookies and other technologies on this website to enhance your user experience.
By clicking any link on this page you are giving your consent to our Privacy Policy and Cookies Policy.
Learn More about Policies